BlackRock Fund Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $8.91M | Buy |
1,284,014
+177,486
| +16% | +$1.23M | ﹤0.01% | 2638 |
|
|
2016
Q3 | $5.63M | Buy |
1,106,528
+75,755
| +7% | +$386K | ﹤0.01% | 2791 |
|
|
2016
Q2 | $6.15M | Buy |
1,030,773
+942,472
| +1,067% | +$5.63M | ﹤0.01% | 2680 |
|
|
2016
Q1 | $402K | Sell |
88,301
-6,574
| -7% | -$29.9K | ﹤0.01% | 3270 |
|
|
2015
Q4 | $427K | Buy |
94,875
+4,447
| +5% | +$20K | ﹤0.01% | 3304 |
|
|
2015
Q3 | $287K | Sell |
90,428
-14,453
| -14% | -$45.9K | ﹤0.01% | 3358 |
|
|
2015
Q2 | $318K | Sell |
104,881
-901,698
| -90% | -$2.73M | ﹤0.01% | 3342 |
|
|
2015
Q1 | $2.97M | Buy |
1,006,579
+19,748
| +2% | +$58.2K | ﹤0.01% | 3044 |
|
|
2014
Q4 | $4.38M | Buy |
986,831
+165,238
| +20% | +$734K | ﹤0.01% | 2946 |
|
|
2014
Q3 | $4.23M | Sell |
821,593
-34,423
| -4% | -$177K | ﹤0.01% | 2847 |
|
|
2014
Q2 | $4.49M | Buy |
856,016
+754,282
| +741% | +$3.96M | ﹤0.01% | 2898 |
|
|
2014
Q1 | $423K | Buy |
101,734
+453
| +0.4% | +$1.88K | ﹤0.01% | 3275 |
|
|
2013
Q4 | $296K | Buy |
101,281
+4,230
| +4% | +$12.4K | ﹤0.01% | 3321 |
|
|
2013
Q3 | $245K | Buy |
97,051
+7,560
| +8% | +$19.1K | ﹤0.01% | 3326 |
|
|
2013
Q2 | $186K | Buy |
+89,491
| New | +$186K | ﹤0.01% | 3348 |
|